Population Pharmacokinetics of Commonly Used Antimicrobial Agents in Children of Bacterial Meningitis With Augmented Renal Clearance
NCT04771884 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2021-04-13
Summary
The investigator's purpose is to study the population pharmacokinetics of commonly used antimicrobial agents in children of bacterial meningitis with augmented renal clearance and assess dosage individualization feasibility.
Conditions
- Bacterial Meningitis
- Augmented Renal Clearance
Interventions
- DRUG
-
meropenem vancomycin ceftazidime ceftriaxone ceftizoxime linezolid
The use of antimicrobial agents depends on the clinical practice
Sponsors & Collaborators
-
Children's Hospital of Chongqing Medical University
collaborator OTHER -
Shandong University
lead OTHER
Eligibility
- Min Age
- 2 Months
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-10-01
- Primary Completion
- 2026-01-20
- Completion
- 2026-03-20
- FDA Drug
- Yes
Countries
- China
Study Locations
More Related Trials
-
A Study to Investigate PK, Safety, Tolerability of Cefepime-enmetazobactam in Pediatric Participants With cUTI
NCT05826990 ·Status: RECRUITING ·Phase: PHASE2
-
Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections
NCT02687906 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Population Pharmacokinetic-pharmacodynamic (PK-PD) Study of 9 Broad-Spectrum Anti-infective Agents in the Cerebro Spinal Fluid (CSF) of Brain Injured Patients With an External Ventricular Drainage (EVD).
NCT03481569 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants.
NCT04126031 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)
NCT01530763 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Children With Complicated Urinary Tract Infection, Including Acute Pyelonephritis
NCT06672978 ·Status: RECRUITING ·Phase: PHASE2
-
Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections
NCT00621192 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pharmacokinetics of Antibiotics in Patients Undergoing Renal Replacement Therapies
NCT03636464 ·Status: RECRUITING
-
Ceftazidime Pharmacokinetic in Cerebrospinal Fluid Between Continuous and Intermittent Administration
NCT00752882 ·Status: UNKNOWN ·Phase: PHASE2
-
The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring
NCT03790631 ·Status: COMPLETED
-
Antibiotic Dosing in Pediatric Intensive Care
NCT02456974 ·Status: RECRUITING
-
Pharmacokinetics of Antibiotics in Critically Ill Patients Receiving CVVHF
NCT04800952 ·Status: UNKNOWN ·Phase: NA
-
Epidemiology of Klebsiella Pneumoniae in China
NCT03598543 ·Status: UNKNOWN
-
Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)
NCT06426836 ·Status: RECRUITING ·Phase: NA
-
P1, DDI & MAD PK and Safety Study of Xeruborbactam Oral Prodrug in Combo With Ceftibuten in Healthy Participants
NCT06079775 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Community Acquired Pneumonia (CABP)
NCT01669980 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Therapeutic Drug Monitoring of Cefazolin in Continuous Renal Replacement Therapy
NCT03672149 ·Status: UNKNOWN ·Phase: PHASE1
-
Risk Factors for Colonization or Infection With Carbapenem-Resistant Enterobacteriaceae in Children
NCT04535661 ·Status: RECRUITING
-
Is Cefazolin, Ceftazidime and Ciprofloxacin Dosing Optimal in Hemodialysis Patients?
NCT04319328 ·Status: COMPLETED
-
A Study of Doripenem in Infants Less Than 12 Weeks of Age
NCT01381848 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile
NCT01744730 ·Status: COMPLETED ·Phase: PHASE1
-
Precision Dosing of Beta-lactam Antibiotics in Critically Ill Children
NCT06929702 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Comparing Tigecycline Vs. Colistimethate in CNS Infections
NCT06702943 ·Status: NOT_YET_RECRUITING
-
Therapeutic Monitoring of Vancomycin in Critical Ill Patients: a Registry
NCT02896218 ·Status: UNKNOWN
-
Colistin Pharmacokinetics in Continuous Renal Replacement Therapy
NCT02081560 ·Status: UNKNOWN ·Phase: PHASE4